Evidence map›Paper›PMID 41254388›Full record

ArticleAnalytical and bioanalytical chemistry2025

CID fragment annotation from data-independent experiments in non-target organic aerosol analysis: presenting an easy-to-use tool.

Niklas Karbach, Thorsten Hoffmann

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Niklas KarbachJohannes-Gutenberg University Mainz, 55128, Mainz, Germany.
Thorsten HoffmannJohannes-Gutenberg University Mainz, 55128, Mainz, Germany. t.hoffmann@uni-mainz.de.

Funding

Bundesministerium für Bildung und Forschung 01LK1602DBundesministerium für Bildung und Forschung Projekt ATTO+Deutsche Forschungsgemeinschaft HO 1748/19-1Deutsche Forschungsgemeinschaft HO 1748/23-1Deutsche Forschungsgemeinschaft TRR 301 - Project-ID 428312742
6 · The paper itself

Abstract

The open-source tool presented in this work provides a simple, reliable, and comprehensive method for analyzing and annotating CID fragments of precursor ions in data-independent full MS/AIF experiments in non-targeted HPLC-UHRMS analyses (NTA). The method provides similar results to established data-dependent fragmentation experiments while simultaneously increasing the informational value of the resulting raw data file, giving a more unbiased view of the sample, which is crucial for NTA, and improving the limit of detection for fragment ions. Using the tool to analyze a mixture of 28 standard compounds has shown that fragment identification and annotation were equal to or better for 71% of the measured compounds - compared to manual analysis - while being completely automated and not requiring input from the experimenter. Formula prediction performed better, with the tool being able to correctly identify 96% of the standard compounds. The purpose of this paper is to provide an easy-to-use tool to facilitate the usage of full MS/AIF measurements for non-targeted analysis, automating the process of fragment annotation and identification for structural analysis of precursor ions. The proposed workflow will significantly increase the informational value of each measurement file, allowing for the creation of databases, and ultimately speed up scientific progress. The algorithm presented in this work yields comparable results as would be obtained by manual analysis of isolated MS

Indexed as

CID fragment identificationLC/HRMSNon-target analysisOrganic aerosol

Identifiers

PMID41254388
PMCPMC12680884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.